OUTAGE: Please be advised that we are experiencing a service outage with our elearning website, and there is no access to "My Training" and CPE training courses.
News View all news
Icahn backs down on Cigna-Express Scripts deal
After two proxy-advisory firms recommended that shareholders back the proposed merger of Cigna and Express Scripts, billionaire activist investor Carl Icahn said Monday that he has dropped his plan to solicit votes from Cigna shareholders against the $54 billion deal.
FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
FDA has approved patisiran (Onpattro—Alnylam Pharmaceuticals) infusion for the treatment of peripheral nerve disease caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults. This is the first FDA-approved treatment for individuals with polyneuropathy caused by hATTR.
August 14, 2018
Can an app or online questionnaire alone replace services…
Historically, there’s been tension between OTC manufacturers who want access to their products to be unfettered and health professionals who would prefer that consumers have access to help that…1 comment
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.